Therefore, the interaction of these proteins with monoaminergic transporters might be relevant in condition, such as schizophrenia, bipolar disorders and claustrophobia, which have been associated with polymorphisms in the M6a gene [88–90], or with the learning and behavioral problems developed in patients with a de novo duplication of the M6a gene [91]. This evidence concerns the gene GPM6A and schizophrenia.